AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $4.407M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 09.59am 31/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 0.4¢ | Day High | 0.4¢ | Day Low | 0.4¢ | |||
| Daily Volume | 12340 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 0.4¢ | 9469076 | 0 | 0.5¢ | 717888 | |
Directors & Senior Management
| Mr. Alistair Hugh Waddell | Member of Advisory Board |
| Mr. Andrew John Haythorpe | Independent Non-Executive Director |
| Mr. Andrew Lorne Johnstone | Member of Advisory Board |
| Mr. Brian Gerry Moller | Non-Executive Chairman |
| Mr. Damien Reynolds | Founder & Business Development Consultant |
| Mr. Donald Charles Smith | MD, CEO & Director |
| Mr. John Williamson | Member of Advisory Board |
| Mr. Owen Burchell | Non-Executive Director |
| Mr. Paul Mario Jurman | CFO & Company Secretary |
| Ms. Sally Bevington | Exploration Manager |
Data source: ADVFN
